NETWORK-1 TECHNOLOGIES, INC. Annual Report - A Deep Dive for Investors

Unlock the insights from NETWORK-1 TECHNOLOGIES, INC.'s (NTIP) latest annual report. We've distilled the key information to provide a clear, jargon-free understanding of their performance, strategy, and what it means for you as an investor.

Business Overview: What NETWORK-1 Does

NETWORK-1 TECHNOLOGIES, INC. (NTIP) operates as an intellectual property (IP) company. They acquire, develop, and license patent portfolios to other companies, generating revenue by allowing others to use their patented technologies.

In 2025, the company continued to focus on managing and monetizing its patent assets. Here are their key patent groups:

• M2M/IoT Patent Portfolio: This portfolio includes technologies vital for Machine-to-Machine (M2M) communication and the Internet of Things (IoT), such as eSIMs. They hold 45 U.S. and 14 foreign patents in this area, with the earliest expiring in 2033. The company actively pursues licensing opportunities for these patents.
• HFT Patent Portfolio: This portfolio focuses on high-frequency trading technologies that enhance trading system speed. It includes 11 U.S. patents, expiring between 2039 and 2040, which they also aim to monetize.
• Cox Patent Portfolio: These patents, related to identifying online media content, have all expired. However, NETWORK-1 has a pending court appeal against Google and YouTube regarding past use of these patents.
• Smart Home Patent Portfolio: An emerging area, this portfolio is under development and aims to facilitate interoperability among various smart home devices.
• Remote Power Patent: This patent, covering Power over Ethernet (PoE) technology, historically generated significant revenue. It expired in 2025, and the company no longer plans to monetize it.
• Mirror Worlds Patent Portfolio: These patents, which relate to how computers search, index, and display documents, have also expired. The company will not monetize them further.

A Pivotal Shift: The expiration of the Remote Power Patent marks the most significant development this year. This patent was NETWORK-1's sole revenue source in both 2024 and 2025. Its expiration means the company's future revenue now depends entirely on its ability to successfully license its other active patent portfolios, particularly M2M/IoT and HFT. This represents a fundamental transition in their business model.

Strategic Diversification: Beyond core IP licensing, NETWORK-1 made a notable $7 million investment in ILiAD Biotechnologies, Inc., a company developing a whooping cough vaccine. As of December 31, 2025, NETWORK-1 owned approximately 6.4% of ILiAD, signaling a move to diversify its assets.

Financial Performance: Revenue, Profit, and Key Metrics

The Remote Power Patent's expiration significantly impacts the company's financial performance. This patent generated over $188 million in revenue from May 2007 through December 31, 2025.

• Revenue: In 2025, NETWORK-1 reported $22.1 million in revenue, a decrease from $28.5 million in 2024. All revenue in both years came solely from the Remote Power Patent. This decline reflects the patent nearing its expiration and potentially fewer or smaller licensing agreements.
• Net Income: The company reported net income of $6.8 million in 2025, down from $12.3 million in 2024. This profitability reduction stems primarily from decreased revenue and potentially higher operating expenses for developing and enforcing newer patent portfolios.
• Earnings Per Share (EPS): Based on approximately 25 million shares outstanding, EPS was $0.27 in 2025, compared to $0.49 in 2024.

With its primary revenue stream now gone, the company faces the immediate challenge of generating new, substantial licensing income from its remaining portfolios.

Management's Discussion and Analysis (MD&A) Highlights

Management's discussion highlights the significant transition following the Remote Power Patent's expiration, which historically provided the company's sole revenue.

Results of Operations: The revenue decline from $28.5 million in 2024 to $22.1 million in 2025, and the corresponding net income decrease from $12.3 million to $6.8 million, stem directly from the Remote Power Patent's diminishing returns as it neared expiration. This expiration presents the major challenge for the company. Management actively mitigates this impact by pursuing licensing opportunities for its M2M/IoT and HFT patent portfolios, which are now critical for future revenue. Ongoing efforts include active licensing discussions and pending lawsuits related to these M2M/IoT and HFT patents. The ongoing appeal for the expired Cox patents also offers potential, though uncertain, future recovery. The $7 million strategic investment in ILiAD Biotechnologies clearly diversifies their asset base, potentially tapping into a different growth sector and reducing sole reliance on patent licensing.

Liquidity and Capital Resources: As detailed in the Financial Health section, the company maintains a strong liquidity position with $36.9 million in cash, cash equivalents, and marketable securities, and $36.3 million in working capital, with no significant long-term debt. Management believes these resources sufficiently fund operations and strategic initiatives, including patent enforcement and development, for the foreseeable future—a crucial aspect during this transitional period.

Critical Accounting Policies and Estimates: The company prepares its financial statements according to U.S. GAAP, which requires management to make estimates and judgments affecting reported amounts. Key areas often involve valuing intellectual property, recognizing revenue from licensing agreements, and estimating litigation outcomes.

Financial Health: Cash, Debt, and Liquidity

As of December 31, 2025, NETWORK-1 TECHNOLOGIES, INC. holds a solid financial position:

• Cash and Marketable Securities: They held $36.9 million in cash, cash equivalents, and marketable securities.
• Working Capital: The company reported $36.3 million in working capital, indicating a healthy ability to cover short-term liabilities.
• Debt: The company maintains a strong balance sheet with no significant long-term debt.

Management believes this robust cash position provides sufficient liquidity to fund operations for the "foreseeable future," a crucial aspect as they navigate this transitional period.

Key Risks That Could Impact the Stock Price

Investors should be aware of several significant risks:

• Loss of Primary Revenue Source: The most immediate risk is the complete loss of revenue from the Remote Power Patent. The company's future success now depends entirely on its ability to generate substantial licensing revenue from its M2M/IoT and HFT portfolios.
• Uncertainty of Patent Monetization: Licensing new patent portfolios can be a lengthy, complex, and unpredictable process, often involving costly litigation. There is no guarantee their new portfolios will generate revenue comparable to the Remote Power Patent.
• Litigation Outcomes: The success of their ongoing patent litigations and appeals (e.g., Cox patents) is uncertain. Adverse outcomes could lead to significant legal expenses without corresponding revenue.
• Investment Performance: The value of their investment in ILiAD Biotechnologies faces the inherent risks of the biotechnology sector, including clinical trial success, regulatory approvals, and market adoption.
• Competition and Patent Enforcement: The IP licensing landscape is highly competitive. Enforcing patent rights can be challenging due to evolving legal interpretations and the high cost of litigation.

Competitive Position

NETWORK-1 operates in a specialized niche, acquiring and monetizing high-quality intellectual property. Their competitive advantage stems from their expertise in identifying valuable patents and navigating complex licensing and litigation. However, this model faces inherent challenges from IP competitors, dynamic patent law, and significant enforcement costs. Their strategy of acquiring new, high-quality patents and collaborating with inventors is key to maintaining their pipeline.

Future Outlook

NETWORK-1 is clearly in a critical transitional phase. The company's future hinges on its ability to successfully develop and monetize its M2M/IoT and HFT patent portfolios, replacing revenue previously generated by the Remote Power Patent. While their strong cash position provides a vital runway, the success of these new monetization efforts will primarily determine their long-term financial health and growth. The ILiAD investment offers a potential alternative growth avenue, but its impact remains long-term and speculative.

Leadership and Strategy Changes

The company's core strategy remains consistent: developing, licensing, and protecting intellectual property. They continue to seek opportunities to acquire additional high-quality patents and collaborate with inventors. The ILiAD Biotechnologies investment represents a strategic expansion, demonstrating a willingness to explore opportunities beyond their traditional IP licensing model to diversify assets and potential revenue streams.

Market Trends and Regulatory Changes Affecting Them

The company operates within a dynamic legal and technological landscape. Evolving patent law, including court decisions and legislative changes, can significantly impact their patent portfolios' enforceability and value. The rapid growth of the Internet of Things (IoT) and Machine-to-Machine (M2M) communication presents a favorable market trend for their M2M/IoT portfolio, offering significant future licensing potential. However, inherent risks and costs associated with patent litigation remain a constant factor in their business model.